Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Nuvectis Pharma, Inc.

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Jul-27-20
   10-K10-K10-K10-K
Revenues  2.40.89.50.0
            Revenue growth  215.2%-91.9%  
Cost of goods sold  1.80.419.10.0
Gross profit  0.70.4-9.50.0
            Gross margin  28.1%46.6%-100.0% 
Selling, general and administrative   [+]6.73.73.30.0
Research and development  13.29.5  
EBIT   [+]-19.2-12.9-12.90.0
            EBIT margin  -787.3%-1663.7%-135.1% 
Other income (expense), net  0.10.00.0 
Pre-tax income  -19.1-12.9-12.90.0
Income taxes  0.00.00.00.0
            Tax rate  0.0%0.0%0.0%0.0%
Net income  -19.1-12.9-12.90.0
            Net margin  -781.2%-1663.2%-135.0% 
   
Basic EPS   [+]($1.51)($3.02)$0.00$0.00
Diluted EPS   [+]($1.51)($3.02)$0.00$0.00
   
Shares outstanding (basic)   [+]12.74.34,268.33,900.0
Shares outstanding (diluted)   [+]12.74.34,268.33,900.0
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy